Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Continuous glucose monitoring-based technologies in hypoglycaemia-prone patients with type 1 diabetes.

Hermanns N, Ehrmann D, Kulzer B.

Lancet Diabetes Endocrinol. 2019 Jun;7(6):419-421. doi: 10.1016/S2213-8587(19)30146-9. Epub 2019 Apr 29. No abstract available.

PMID:
31047900
2.

Comparison of the efficacy of an education program for people with diabetes and insulin pump treatment (INPUT) in a randomized controlled trial setting and the effectiveness in a routine care setting: Results of a comparative effectiveness study.

Bergis D, Ehrmann D, Albrecht C, Haak T, Kulzer B, Hermanns N.

Patient Educ Couns. 2019 Apr 18. pii: S0738-3991(19)30141-7. doi: 10.1016/j.pec.2019.04.021. [Epub ahead of print]

PMID:
31031097
3.

Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index.

Leelarathna L, Thabit H, Wilinska ME, Bally L, Mader JK, Pieber TR, Benesch C, Arnolds S, Johnson T, Heinemann L, Hermanns N, Evans ML, Hovorka R.

J Diabetes Sci Technol. 2019 Mar 31:1932296819838525. doi: 10.1177/1932296819838525. [Epub ahead of print]

PMID:
30931606
4.

The impact of a structured education and treatment programme (FLASH) for people with diabetes using a flash sensor-based glucose monitoring system: Results of a randomized controlled trial.

Hermanns N, Ehrmann D, Schipfer M, Kröger J, Haak T, Kulzer B.

Diabetes Res Clin Pract. 2019 Apr;150:111-121. doi: 10.1016/j.diabres.2019.03.003. Epub 2019 Mar 4.

5.

Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study.

Hermanns N, Heinemann L, Freckmann G, Waldenmaier D, Ehrmann D.

J Diabetes Sci Technol. 2019 Mar 6:1932296819831695. doi: 10.1177/1932296819831695. [Epub ahead of print]

PMID:
30841740
6.

Comment on the consensus report on the management of hyperglycaemia in Type 2 diabetes by the American Diabetes Association and the European Association for the Study of Diabetes.

Skinner T, Byrne M, Dickinson JK, Fisher L, Funnell M, Guzman S, Hendrieckx C, Hermanns N, Kanc K, Lloyd C, Mocan A, Nouwen A, Pouwer F, Saleh-Stattin N, Snoek F, Speight J, Sturt J, Vallis M, Wagner J, Willaing I, Young-Hyman D, Zoffmann V.

Diabet Med. 2019 Jul;36(7):911-912. doi: 10.1111/dme.13934. Epub 2019 Apr 3. No abstract available.

PMID:
30785642
7.

Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes.

Herder C, Hermanns N.

Semin Immunopathol. 2019 Feb 18. doi: 10.1007/s00281-019-00730-x. [Epub ahead of print] Review.

PMID:
30778653
8.

Identifying solutions to psychological insulin resistance: An international study.

Polonsky WH, Fisher L, Hessler D, Stuckey H, Snoek FJ, Tang T, Hermanns N, Mundet X, Silva M, Sturt J, Okazaki K, Hadjiyianni I, Cao D, Ivanova J, Desai U, Perez-Nieves M.

J Diabetes Complications. 2019 Apr;33(4):307-314. doi: 10.1016/j.jdiacomp.2019.01.001. Epub 2019 Jan 17.

9.

The Effects and Effect Sizes of Real-Time Continuous Glucose Monitoring on Patient-Reported Outcomes: A Secondary Analysis of the HypoDE Study.

Ehrmann D, Heinemann L, Freckmann G, Waldenmaier D, Faber-Heinemann G, Hermanns N.

Diabetes Technol Ther. 2019 Feb;21(2):86-93. doi: 10.1089/dia.2018.0332. Epub 2019 Jan 7.

PMID:
30615479
10.

Efficacy of an Education Program for People With Diabetes and Insulin Pump Treatment (INPUT): Results From a Randomized Controlled Trial.

Ehrmann D, Kulzer B, Schipfer M, Lippmann-Grob B, Haak T, Hermanns N.

Diabetes Care. 2018 Dec;41(12):2453-2462. doi: 10.2337/dc18-0917. Epub 2018 Oct 10.

PMID:
30305343
11.

Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes.

Herder C, Schmitt A, Budden F, Reimer A, Kulzer B, Roden M, Haak T, Hermanns N.

Psychoneuroendocrinology. 2018 May;91:216-225. doi: 10.1016/j.psyneuen.2018.02.032. Epub 2018 Mar 6.

PMID:
29525039
12.

Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes-potential differences by diabetes type and depression scores.

Herder C, Schmitt A, Budden F, Reimer A, Kulzer B, Roden M, Haak T, Hermanns N.

Transl Psychiatry. 2018 Mar 9;7(11):1. doi: 10.1038/s41398-017-0009-2.

13.

Comment on Young-Hyman et al. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126-2140.

Snoek FJ, Hermanns N, de Wit M, Huber J, Sturt J, Pouwer F, Lloyd CE, Willaing I, Nouwen A; Psychosocial Aspects of Diabetes Study Group of the European Association for the Study of Diabetes.

Diabetes Care. 2018 Mar;41(3):e31-e32. doi: 10.2337/dc17-1102. No abstract available.

PMID:
29463671
14.

Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.

Heinemann L, Freckmann G, Ehrmann D, Faber-Heinemann G, Guerra S, Waldenmaier D, Hermanns N.

Lancet. 2018 Apr 7;391(10128):1367-1377. doi: 10.1016/S0140-6736(18)30297-6. Epub 2018 Feb 16.

PMID:
29459019
15.

Measurement of psychological adjustment to diabetes with the diabetes acceptance scale.

Schmitt A, Reimer A, Kulzer B, Icks A, Paust R, Roelver KM, Kaltheuner M, Ehrmann D, Krichbaum M, Haak T, Hermanns N.

J Diabetes Complications. 2018 Apr;32(4):384-392. doi: 10.1016/j.jdiacomp.2018.01.005. Epub 2018 Jan 31.

PMID:
29439862
17.

Adherence Over Time: The Course of Adherence to Customized Diabetic Insoles as Objectively Assessed by a Temperature Sensor.

Ehrmann D, Spengler M, Jahn M, Niebuhr D, Haak T, Kulzer B, Hermanns N.

J Diabetes Sci Technol. 2018 May;12(3):695-700. doi: 10.1177/1932296817747618. Epub 2017 Dec 27.

18.

Reduction of depressive symptoms predicts improved glycaemic control: Secondary results from the DIAMOS study.

Schmitt A, Reimer A, Ehrmann D, Kulzer B, Haak T, Hermanns N.

J Diabetes Complications. 2017 Nov;31(11):1608-1613. doi: 10.1016/j.jdiacomp.2017.08.004. Epub 2017 Aug 9.

PMID:
28865713
19.

Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully.

Polonsky WH, Arsenault J, Fisher L, Kushner P, Miller EM, Pearson TL, Tracz M, Harris S, Hermanns N, Scholz BM, Pollom RK, Perez-Nieves M, Pollom RD, Hadjiyianni I.

Int J Clin Pract. 2017 Aug;71(8). doi: 10.1111/ijcp.12973. Epub 2017 Jul 23. No abstract available.

20.

Reduction of diabetes-related distress predicts improved depressive symptoms: A secondary analysis of the DIAMOS study.

Reimer A, Schmitt A, Ehrmann D, Kulzer B, Hermanns N.

PLoS One. 2017 Jul 10;12(7):e0181218. doi: 10.1371/journal.pone.0181218. eCollection 2017.

21.

The affective and somatic side of depression: subtypes of depressive symptoms show diametrically opposed associations with glycemic control in people with type 1 diabetes.

Ehrmann D, Schmitt A, Reimer A, Haak T, Kulzer B, Hermanns N.

Acta Diabetol. 2017 Aug;54(8):749-756. doi: 10.1007/s00592-017-1006-x. Epub 2017 May 29.

PMID:
28555338
22.

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes.

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G.

Diabetes Ther. 2017 Jun;8(3):573-586. doi: 10.1007/s13300-017-0255-6. Epub 2017 Apr 11.

23.

How Much Accuracy of Interstitial Glucose Measurement Is Enough? Is There a Need for New Evidence?

Hermanns N, Ehrmann D, Kulzer B.

J Diabetes Sci Technol. 2017 Mar;11(2):296-298. doi: 10.1177/1932296816677578. Epub 2016 Nov 10. Review.

24.

The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.

Hermanns N, Ehrmann D, Schall S, Maier B, Haak T, Kulzer B.

Diabet Med. 2017 Aug;34(8):1084-1091. doi: 10.1111/dme.13346. Epub 2017 Apr 2.

PMID:
28257159
25.

Salmonella enterica Remodels the Host Cell Endosomal System for Efficient Intravacuolar Nutrition.

Liss V, Swart AL, Kehl A, Hermanns N, Zhang Y, Chikkaballi D, Böhles N, Deiwick J, Hensel M.

Cell Host Microbe. 2017 Mar 8;21(3):390-402. doi: 10.1016/j.chom.2017.02.005. Epub 2017 Feb 23.

26.

Depression is linked to hyperglycaemia via suboptimal diabetes self-management: A cross-sectional mediation analysis.

Schmitt A, Reimer A, Hermanns N, Kulzer B, Ehrmann D, Krichbaum M, Huber J, Haak T.

J Psychosom Res. 2017 Mar;94:17-23. doi: 10.1016/j.jpsychores.2016.12.015. Epub 2016 Dec 29.

PMID:
28183398
27.

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G.

Diabetes Ther. 2017 Feb;8(1):55-73. doi: 10.1007/s13300-016-0223-6. Epub 2016 Dec 20.

28.

Female sex, young age, northern German residence, hypoglycemia and disabling diabetes complications are associated with depressed mood in the WHO-5 questionnaire - A multicenter DPV study among 17,563 adult patients with type 2 diabetes.

Prinz N, Ebner S, Grünerbel A, Henkelüdecke U, Hermanns N, Hummel M, Schäfer C, Wagner C, Weiland J, Welp R, Holl RW.

J Affect Disord. 2017 Jan 15;208:384-391. doi: 10.1016/j.jad.2016.08.077. Epub 2016 Oct 11.

PMID:
27810722
29.

Correlates and outcomes of worries about hypoglycemia in family members of adults with diabetes: The second Diabetes Attitudes, Wishes and Needs (DAWN2) study.

Nefs G, Pouwer F, Holt RI, Skovlund S, Hermanns N, Nicolucci A, Peyrot M.

J Psychosom Res. 2016 Oct;89:69-77. doi: 10.1016/j.jpsychores.2016.07.017. Epub 2016 Aug 2.

PMID:
27663113
30.

hs-CRP Predicts Improvement in Depression in Patients With Type 1 Diabetes and Major Depression Undergoing Depression Treatment: Results From the Diabetes and Depression (DAD) Study.

Zahn D, Herpertz S, Albus C, Hermanns N, Hiemke C, Hiller W, Kronfeld K, Kruse J, Kulzer B, Müller MJ, Ruckes C, Petrak F.

Diabetes Care. 2016 Oct;39(10):e171-3. doi: 10.2337/dc16-0710. Epub 2016 Aug 3. No abstract available.

PMID:
27489334
31.

Assessing Diabetes Self-Management with the Diabetes Self-Management Questionnaire (DSMQ) Can Help Analyse Behavioural Problems Related to Reduced Glycaemic Control.

Schmitt A, Reimer A, Hermanns N, Huber J, Ehrmann D, Schall S, Kulzer B.

PLoS One. 2016 Mar 3;11(3):e0150774. doi: 10.1371/journal.pone.0150774. eCollection 2016.

32.

Development of a New Tool to Assess Bolus Calculation and Carbohydrate Estimation.

Ehrmann D, Hermanns N, Reimer A, Weißmann J, Haak T, Kulzer B.

Diabetes Technol Ther. 2016 Mar;18(3):194-9. doi: 10.1089/dia.2015.0292. Epub 2016 Feb 23.

PMID:
26907638
33.
34.

How should we treat people with diabetes and comorbid depression?

Hermanns N, Ehrmann D, Kulzer B.

J Diabetes Complications. 2016 Mar;30(2):187-8. doi: 10.1016/j.jdiacomp.2015.11.023. Epub 2015 Dec 2. No abstract available.

PMID:
26785713
35.
36.
37.

How to assess diabetes distress: comparison of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS).

Schmitt A, Reimer A, Kulzer B, Haak T, Ehrmann D, Hermanns N.

Diabet Med. 2016 Jun;33(6):835-43. doi: 10.1111/dme.12887. Epub 2015 Sep 8.

PMID:
26287511
38.

IQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial.

Heinemann L, Hermanns N.

J Diabetes Sci Technol. 2015 Aug 6;10(1):185-90. doi: 10.1177/1932296815597918.

39.

Longitudinal relationship of diabetes-related distress and depressive symptoms: analysing incidence and persistence.

Ehrmann D, Kulzer B, Haak T, Hermanns N.

Diabet Med. 2015 Oct;32(10):1264-71. doi: 10.1111/dme.12861. Epub 2015 Aug 20.

PMID:
26202341
40.

Does treatment of subsyndromal depression improve depression-related and diabetes-related outcomes? A randomised controlled comparison of psychoeducation, physical exercise and enhanced treatment as usual.

Pibernik-Okanović M, Hermanns N, Ajduković D, Kos J, Prašek M, Šekerija M, Lovrenčić MV.

Trials. 2015 Jul 15;16:305. doi: 10.1186/s13063-015-0833-8.

41.
42.

Constructs of depression and distress in diabetes: time for an appraisal.

Snoek FJ, Bremmer MA, Hermanns N.

Lancet Diabetes Endocrinol. 2015 Jun;3(6):450-460. doi: 10.1016/S2213-8587(15)00135-7. Epub 2015 May 17. Review.

PMID:
25995123
43.

Patient-reported outcomes and continuous glucose monitoring: can we do better with artificial pancreas devices?

Barnard KD, Kubiak T, Hermanns N, Heinemann L.

Diabetes Care. 2015 May;38(5):e70. doi: 10.2337/dc14-3044. No abstract available.

PMID:
25908157
44.
45.

Cognitive Behavioral Therapy Versus Sertraline in Patients With Depression and Poorly Controlled Diabetes: The Diabetes and Depression (DAD) Study: A Randomized Controlled Multicenter Trial.

Petrak F, Herpertz S, Albus C, Hermanns N, Hiemke C, Hiller W, Kronfeld K, Kruse J, Kulzer B, Ruckes C, Zahn D, Müller MJ.

Diabetes Care. 2015 May;38(5):767-75. doi: 10.2337/dc14-1599. Epub 2015 Feb 17.

PMID:
25690005
46.

Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot study.

Hermanns N, Lilly LC, Mader JK, Aberer F, Ribitsch A, Kojzar H, Warner J, Pieber TR.

J Diabetes Sci Technol. 2015 May;9(3):581-7. doi: 10.1177/1932296815570709. Epub 2015 Feb 9.

47.

Depressive symptoms prior to and following insulin initiation in patients with type 2 diabetes mellitus: Prevalence, risk factors and effect on physician resource utilisation.

Dzida G, Karnieli E, Svendsen AL, Sølje KS, Hermanns N; SOLVE Study Group.

Prim Care Diabetes. 2015 Oct;9(5):346-53. doi: 10.1016/j.pcd.2015.01.002. Epub 2015 Jan 30.

48.

The effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial.

Hermanns N, Schmitt A, Gahr A, Herder C, Nowotny B, Roden M, Ohmann C, Kruse J, Haak T, Kulzer B.

Diabetes Care. 2015 Apr;38(4):551-60. doi: 10.2337/dc14-1416. Epub 2015 Jan 20.

PMID:
25605812
49.

Improved insulin absorption by means of standardized injection site modulation results in a safer and more efficient prandial insulin treatment. A review of the existing clinical data.

Pfützner A, Raz I, Bitton G, Klonoff D, Nagar R, Hermanns N, Haak T.

J Diabetes Sci Technol. 2015 Jan;9(1):116-22. doi: 10.1177/1932296814555400. Epub 2014 Oct 28. Review.

50.

Coronary artery disease as an independent predictor of survival in patients with type 2 diabetes and Charcot neuro-osteoarthropathy.

Bergis D, Bergis PM, Hermanns N, Zink K, Haak T.

Acta Diabetol. 2014 Dec;51(6):1041-8. doi: 10.1007/s00592-014-0669-9. Epub 2014 Oct 26.

PMID:
25344769

Supplemental Content

Loading ...
Support Center